Implications of Food and Drug Administration Approval of Respiratory Syncytial Virus Prophylactic Medication

• 2023

  Log in to bookmark this resource.

  Log in
• Ashley Saint-Fleur; Catherine Kier
PMID: 37779223DOI: https://dx.doi.org/10.1542/pir.2023-006246

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This brief article discusses the implications of the FDA approval of nirsevimab, a monoclonal antibody, for preventing respiratory syncytial virus (RSV) lower respiratory tract infections (LRTIs) in infants and toddlers. RSV is a common cause of LRTIs and hospitalizations among young children. The approval of nirsevimab expands preventive therapies for RSV, especially benefiting high-risk infants. This approval marks progress in combating RSV-related illnesses in vulnerable populations.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Respiratory Syncytial Virus Infections; United States Food and Drug Administration; Drug Approval; Respiratory Syncytial Virus, Human

Institutions: Boston Children's Hospital; Stony Brook Children's Hospital

---

More like this

Implications of Food and Drug Administration Approval of Respiratory Syncytial Virus Prophylactic Medication 2023 · Boston Children's Hospital, Stony Brook Children's Hospital Disparities in the Availability and Acceptance of Nirsevimab in Massachusetts 2024 · Harvard Medical School, Boston Children's Hospital Chemical-Biological Terrorism and Its Impact on Children [2020] 2020 · Harvard Medical School, Boston Children's Hospital, Yale University, Children's Hospital Colorado, University of Colorado, American Academy of Pediatrics (AAP)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---